TU + ENG
Testosterone Undecanoate (TU) + Etonogestrel (ENG)
- User: Male
- Hormonal: Hormonal
-
Delivery type:
- Multiple
- Injectable
- Subdermal
-
Intended Duration:
- Short-Acting
- Development Stage: Phase II
- Developer(s)/researcher(s): Organon
Details
- API: Testosterone Undecanoate, Etonogestrel
- Target: Progesterone Receptor, Androgen Receptor
-
Mechanism of Action:
- Reduced Sperm Production
- Inactive Materials: Undetermined
- Regimen: Undetermined
- MPT: Not Potential MPT
Product Status
After results of the 2006 study were published in 2008, no additional research was completed. 2008 results continue to be broadly cited.
History
A Phase IIb, placebo-controlled trial investigating the efficacy, safety and pharmacokinetics of the product was completed in 2006. This combination has been extensively evaluated by multiple development groups. However, no development is active.